Abstract:Abstract The effect of the gut microbiome on the central nervous system and its possible role in mental disorders have received increasing attention. However, knowledge about the relationship between the gut microbiome and brain structure and function is still very limited. Here, we used 16S rRNA sequencing with structural magnetic resonance imaging (sMRI) and resting-state functional (rs-fMRI) to investigate differences in fecal microbiota between 38 patients with schizophrenia (SZ) and 38 demographically matched normal controls (NCs) and explored whether such differences were associated with brain structure and function. At the genus level, we found that the relative abundance of Ruminococcus and Roseburia was significantly lower, whereas the abundance of Veillonella was significantly higher in SZ patients than in NCs. Additionally, the analysis of MRI data revealed that several brain regions showed significantly lower gray matter volume (GMV) and regional homogeneity (ReHo) but significantly higher amplitude of low-frequency fluctuation in SZ patients than in NCs. Moreover, the alpha diversity of the gut microbiota showed a strong linear relationship with the values of both GMV and ReHo. In SZ patients, the ReHo indexes in the right STC ( r = − 0.35, p = 0.031, FDR corrected p = 0.039), the left cuneus ( r = − 0.33, p = 0.044, FDR corrected p = 0.053) and the right MTC ( r = − 0.34, p = 0.03, FDR corrected p = 0.052) were negatively correlated with the abundance of the genus Roseburia . Our results suggest that the potential role of the gut microbiome in SZ is related to alterations in brain structure and function. This study provides insights into the underlying neuropathology of SZ.

What problem does this paper attempt to address?

The problem this paper attempts to address is the exploration of the relationship between the gut microbiome and the brain structure and function in patients with schizophrenia (SZ). Specifically, the researchers aim to analyze the differences in the fecal microbiome of 38 schizophrenia patients and 38 matched normal controls (NCs) using 16S rRNA sequencing combined with structural magnetic resonance imaging (sMRI) and resting-state functional magnetic resonance imaging (rs-fMRI), and to explore whether these differences are related to changes in brain structure and function. ### Main Research Content: 1. **Differences in the Gut Microbiome**: - The study found significant differences in the gut microbiome at the genus level in schizophrenia patients. Specifically, compared to the normal control group, the relative abundance of Ruminococcus and Roseburia was significantly reduced in schizophrenia patients, while the relative abundance of Veillonella was significantly increased. 2. **Differences in Brain Structure and Function**: - Structural magnetic resonance imaging (sMRI) results showed that schizophrenia patients had significantly reduced gray matter volume (GMV) in multiple brain regions. - Resting-state functional magnetic resonance imaging (rs-fMRI) results showed that schizophrenia patients had significantly reduced regional homogeneity (ReHo) in multiple brain regions, while the amplitude of low-frequency fluctuations (ALFF) was significantly increased in certain brain regions. 3. **Relationship Between the Gut Microbiome and Brain Structure and Function**: - The study found a significant linear relationship between the α-diversity of the gut microbiome and gray matter volume (GMV) and regional homogeneity (ReHo) in the brain. - Specifically, in schizophrenia patients, the ReHo index of the right superior temporal gyrus (STC), left cuneus, and right middle temporal gyrus (MTC) was negatively correlated with the abundance of Roseburia. ### Significance of the Study: - This study is the first to reveal the association between the gut microbiome and brain structure and function in schizophrenia patients, providing a new perspective for understanding the neuropathological mechanisms of schizophrenia. - These findings may provide potential biomarkers and intervention targets for the diagnosis and treatment of schizophrenia. ### Overview of Methods: - **Participants**: A total of 76 participants were recruited, including 38 schizophrenia patients and 38 matched normal controls. - **Sample Collection**: Fecal samples from the participants were collected for 16S rRNA sequencing, and structural magnetic resonance imaging and resting-state functional magnetic resonance imaging were performed. - **Data Analysis**: Statistical analysis methods were used to compare the differences in the gut microbiome and brain structure and function indicators between the two groups and to explore their correlations. ### Conclusion: - The study suggests that changes in the gut microbiome may be related to abnormalities in brain structure and function in schizophrenia patients, providing new clues for further research into the pathogenesis and potential treatment methods for schizophrenia.

The gut microbiome is associated with brain structure and function in schizophrenia

Alteration of the Gut Microbiome in First-Episode Drug-Naïve and Chronic Medicated Schizophrenia Correlate with Regional Brain Volumes.

Crosstalk Between the Gut Microbiota and the Brain: an Update on Neuroimaging Findings

Multiomics Analyses Reveal Microbiome–Gut–Brain Crosstalk Centered on Aberrant Gamma-Aminobutyric Acid and Tryptophan Metabolism in Drug-Naïve Patients with First-Episode Schizophrenia

Gut Microbiome and Magnetic Resonance Spectroscopy Study of Subjects at Ultra-High Risk for Psychosis May Support the Membrane Hypothesis.

Relationships among the gut microbiome, brain networks, and symptom severity in schizophrenia patients: A mediation analysis

Altered gut microbiota associated with symptom severity in schizophrenia

Association between the oral microbiome and brain resting state connectivity in schizophrenia

Unveiling the gut microbiota blueprint of schizophrenia: a multilevel omics approach

Identification of gut microbiome markers for schizophrenia delineates a potential role of Streptococcus

A Comparative Study to Determine the Association of Gut Microbiome with Schizophrenia in Zhejiang, China

Alterations of the gut microbiota in patients with schizophrenia

Metagenome-wide Association of Gut Microbiome Features for Schizophrenia.

Transplantation of gut microbiota derived from patients with schizophrenia induces schizophrenia-like behaviors and dysregulated brain transcript response in mice

Schizophrenia and antipsychotic medications present distinct and shared gut microbial composition: A meta-analysis

Preliminary observation and analysis of the characteristics of gut microbiota in patients with schizophrenia.

Brain Network Topology and Structural–Functional Connectivity Coupling Mediate the Association Between Gut Microbiota and Cognition

Schizophrenia and Gut-Flora Related Epigenetic Factors

Intestinal Microbes in Patients with Schizophrenia Undergoing Short-Term Treatment: Core Species Identification Based on Co-Occurrence Networks and Regression Analysis.

Shotgun metagenomics reveals abnormal short-chain fatty acid-producing bacteria and glucose and lipid metabolism of the gut microbiota in patients with schizophrenia

Analysis of Gut Microbiota Diversity and Auxiliary Diagnosis As a Biomarker in Patients with Schizophrenia: A Cross-Sectional Study